| # | Company | Location | Employees | Total Funding | Last Round | Last Funded |
|---|---|---|---|---|---|---|
| 1 |
Function Health
Function Health is a health platform offering lab tests to help individuals moni…
|
Austin | — | $354.0M | Series B | 2025-11-19 |
| 2 |
OpenEvidence
OpenEvidence is a medical AI company that builds a search engine to support clin…
|
Cambridge | 11 - 50 | $767.0M | Series D | 2026-01-21 |
| 3 |
Neuralink
Neuralink is a neurotechnology company that focuses on developing brain-computer…
|
Fremont | 251 - 500 | $1.3B | Series Unknown | 2025-07-07 |
| 4 |
Honor
Honor Technology provides aging care solutions and home care services.
|
Concord | 501 - 1K | $625.0M | Debt Financing | 2021-10-05 |
| 5 |
Orca Bio
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curati…
|
Menlo Park | 251 - 500 | $542.0M | Series F | 2026-01-09 |
| 6 |
Parabilis Medicines
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specialize…
|
Cambridge | 101 - 250 | $835.3M | Series F | 2026-01-08 |
| 7 |
Alumis
Alumis is a precision medicine company focused on the discovery, development and…
|
San Francisco | 101 - 250 | $917.2M | Post Ipo Equity | 2026-01-07 |
| 8 |
Mediar Therapeutics
Mediar is a pre-clinical stage biotechnology company developing therapeutics for…
|
Cambridge | 11 - 50 | $181.0M | Series B | 2026-01-07 |
| 9 |
Tempus
Tempus develops AI-enabled precision medicine technology that supports clinical …
|
Chicago | 1K - 5K | $2.3B | Post Ipo Debt | 2025-06-30 |
| 10 |
Tebra
Tebra provide independent healthcare practices with digital tools and support to…
|
Corona Del Mar | 501 - 1K | $387.0M | Series Unknown | 2025-12-17 |
| 11 |
Rakuten Medical
Rakuten Medical is a biotechnology company developing investigational cancer the…
|
San Diego | 101 - 250 | $837.6M | Corporate Round | 2026-04-02 |
| 12 |
Diagonal Therapeutics
Diagonal Therapeutics is a biotechnology startup that develops targeted therapie…
|
Watertown | 11 - 50 | $253.0M | Series B | 2026-01-08 |
| 13 |
Alamar Biosciences
Alamar Biosciences develops technologies for the detection and treatment of canc…
|
Fremont | 51 - 100 | $282.0M | Convertible Note | 2026-01-11 |
| 14 |
Corsera Health
Corsera Health develops preventive RNA interference medicines that reduces cardi…
|
Boston | 11 - 50 | $130.0M | Series A | 2026-01-07 |
| 15 |
BrightInsight
BrightInsight offers a global regulated digital health platform for biopharma an…
|
Sunnyvale | 101 - 250 | $179.0M | Series Unknown | 2026-01-20 |
| 16 |
Metsera
Metsera is a clinical-stage biotech firm developing oral & injectable hormone th…
|
New York | 51 - 100 | $505.0M | Series B | 2024-11-13 |
| 17 |
BillionToOne
BillionToOne is a precision diagnostics company that focuses on genetic testing …
|
Menlo Park | 501 - 1K | $425.9M | Series D | 2024-06-21 |
| 18 |
Teal Health
Teal Health is a health tech company that develops cervical cancer screening and…
|
San Francisco | 11 - 50 | $21.5M | Seed | 2025-01-16 |
| 19 |
Galderma
Galderma offering a range of medical and consumer skin health solutions through …
|
Lausanne | 5K - 10K | $9.3B | Post Ipo Secondary | 2025-12-08 |
| 20 |
Kinaset Therapeutics
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel…
|
Boston | 1 - 10 | $144.5M | Series B | 2026-01-10 |
| 21 |
Elation Health
Elation Health is a technology platform designed for independent primary care, d…
|
San Francisco | 101 - 250 | $108.5M | Series D | 2022-07-26 |
| 22 |
Omada Health
Omada Health is a digital behavioral medicine company that helps members change …
|
San Francisco | 501 - 1K | $528.5M | Secondary Market | 2025-05-27 |
| 23 |
ViCentra
ViCentra has developed an insulin pump for diabetes patients.
|
Utrecht | 101 - 250 | $193.9M | Series D | 2026-01-08 |
| 24 |
Isomorphic Labs
Isomorphic Labs provides AI-driven solutions for drug discovery and development.
|
London | 101 - 250 | $601.7M | Series A | 2025-03-31 |
| 25 |
Zarminali Health
Zarminali Health provides pediatric healthcare services and support to streamlin…
|
Chicago | 11 - 50 | $150.0M | Series A | 2026-01-21 |
| 26 |
Aclarion
Aclarion is a healthcare technology company that assists with medical imaging an…
|
Broomfield | 11 - 50 | $48.4M | Post Ipo Equity | 2026-01-08 |
| 27 |
Profusa
PROFUSA is a medical devices company creating tissue-integrated sensors for chro…
|
San Francisco | 51 - 100 | $99.9M | Post Ipo Debt | 2025-07-14 |
| 28 |
FineHeart
FineHeart is a medical device company
|
Bordeaux | 11 - 50 | $146.8M | Grant | 2026-01-08 |
| 29 |
Converge Bio
Converge Bio integrates Generative AI with biological data.
|
Wilmington | 11 - 50 | $30.5M | Series A | 2026-01-13 |
| 30 |
Variant Bio
Variant Bio is leveraging the power of human genetic diversity to discover new t…
|
Seattle | 11 - 50 | $129.7M | Series B | 2021-11-09 |
| 31 |
Distalmotion
Distalmotion is a Swiss medical device company that develops a surgical robot ca…
|
Epalinges | 101 - 250 | $390.2M | Corporate Round | 2026-01-12 |
| 32 |
Talkiatry
Talkiatry provides virtual mental healthcare services covered by insurance, conn…
|
New York | 501 - 1K | $452.0M | Debt Financing | 2026-02-12 |
| 33 |
Heartflow
Heartflow is a medical technology company that provides various methods of diagn…
|
Mountain View | 501 - 1K | $890.7M | Convertible Note | 2025-03-26 |
| 34 |
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery,…
|
Cambridge | 1K - 5K | $4.5B | Post Ipo Debt | 2025-09-09 |
| 35 |
Apella Technology
Apella Technology is an AI startup that brings modern engineering to improve sur…
|
Oakland | 51 - 100 | $104.0M | Series B | 2026-01-07 |
| 36 |
Bactolife
Bactolife is a biotechnology company that develops biological solutions to suppo…
|
Lyngby | 11 - 50 | $81.5M | Series B | 2026-01-06 |
| 37 |
EpiBiologics
EpiBiologics develops antibody-based targeted therapies against membrane and ext…
|
San Mateo | 11 - 50 | $203.1M | Series B | 2026-01-08 |
| 38 |
Pfizer
Pfizer is a biopharmaceutical company that discovers, develops, and delivers med…
|
New York | c 10001 max | $38.0B | Post Ipo Debt | 2025-11-21 |
| 39 |
Cellares
Cellares is an Integrated Development and Manufacturing Organization dedicated t…
|
South San Francisco | 101 - 250 | $612.0M | Series C | 2023-08-23 |
| 40 |
Poplar Therapeutics
Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy…
|
Cambridge | 1 - 10 | $50.0M | Series A | 2026-01-07 |
| 41 |
Relation Therapeutics
Relation Therapeutics is a biotechnology company that focuses on humanizing drug…
|
London | 11 - 50 | $95.0M | Series Unknown | 2025-12-09 |
| 42 |
Fountain Life
Fountain Life is a preventative health and longevity company that offers AI-powe…
|
Naples | 101 - 250 | $115.1M | Series B | 2025-08-13 |
| 43 |
Ambience Healthcare
Ambience Healthcare develops an AI operating system used for documentation, codi…
|
San Francisco | 101 - 250 | $319.3M | Series C | 2025-07-29 |
| 44 |
Cytotheryx
Cytotheryx is a preclinical cell therapy company focused on the development of a…
|
Rochester | 11 - 50 | $60.0M | Debt Financing | 2026-01-12 |
| 45 |
Tennr
Tennr is a healthcare AI startup that provides an automation platform for medica…
|
New York | 51 - 100 | $161.0M | Series C | 2025-06-18 |
| 46 |
Cedar
Cedar is a patient payment and engagement platform for hospitals, health systems…
|
New York | 251 - 500 | $419.4M | Series D | 2022-12-19 |
| 47 |
Curi Bio
Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for…
|
Seattle | 11 - 50 | $30.4M | Series B | 2025-12-02 |
| 48 |
HealthEx
HealthEx builds a patient-centric future for health data collaboration to unlock…
|
San Francisco | 11 - 50 | $14.0M | Series A | 2024-10-21 |
| 49 |
Hello Heart
Hello Heart provides cardiovascular digital therapeutics to help people understa…
|
Menlo Park | 101 - 250 | $138.2M | Series D | 2022-05-02 |
| 50 |
InduPro
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface…
|
Seattle | 11 - 50 | $85.0M | Corporate Round | 2026-01-07 |